uniQure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell uniQure and other ETFs, options, and stocks.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.

CEO

Matthew C. Kapusta

CEOMatthew C. Kapusta

Employees

209

Employees209

Headquarters

Amsterdam, Noord-Holland

HeadquartersAmsterdam, Noord-Holland

Founded

2012

Founded2012

Employees

209

Employees209

QURE Key Statistics

Market cap

3.92B

Market cap3.92B

Price-Earnings ratio

-15.30

Price-Earnings ratio-15.30

Dividend yield

—

Dividend yield—

Average volume

6.42M

Average volume6.42M

High today

$65.12

High today$65.12

Low today

$59.16

Low today$59.16

Open price

$59.87

Open price$59.87

Volume

3.58M

Volume3.58M

52 Week high

$65.12

52 Week high$65.12

52 Week low

$5.23

52 Week low$5.23

Analyst ratings

92%

of 13 ratings

Buy

92.3%

Hold

7.7%

Sell

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.

IREN Limited

Robinhood Markets

Nebius Group

Rocket Lab Corporation

Opendoor Technologies

CoreWeave